VTRS
Viatris Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 150 | -1 | 757.45M | $12.03B | +6 | −6 |
| Q1 2026 | 153 | +6 | 683.49M | $9.23B | +9 | −4 |
| Q4 2025 | 146 | -3 | 743.40M | $9.25B | +1 | −3 |
| Q3 2025 | 22 | -3 | 488.65M | $4.84B | — | −4 |
| Q2 2025 | 23 | +2 | 455.87M | $4.07B | +3 | −1 |
| Q1 2025 | 18 | -1 | 210.93M | $1.84B | +1 | −2 |
| Q4 2024 | 19 | -3 | 200.96M | $2.50B | +1 | −4 |
| Q3 2024 | 21 | +3 | 124.36M | $1.44B | +3 | — |
| Q2 2024 | 18 | — | 121.66M | $1.29B | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 56.82M | — | $604.03M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 56.82M | — | $604.03M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 29.00M | — | $307.45M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasivo) | 29.00M | — | $307.45M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Norges Bank ✦ (pasivo) | 12.65M | — | $134.44M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Greenlight Capital (DME Capital) ✦ | 7.40M | — | $78.66M | 3.8% | n/c | 1 | SEC ↗ |
| 7 | Greenlight Capital (DME Capital) ✦ | 7.40M | — | $78.66M | 3.8% | n/c | 1 | SEC ↗ |
| 8 | Glenview Capital ✦ | 6.49M | — | $69.04M | 1.5% | n/c | 1 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 3.10M | — | $32.72M | 0.1% | n/c | 1 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 3.10M | — | $32.72M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Marshall Wace ✦ | 1.10M | — | $11.70M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Marshall Wace ✦ | 1.10M | — | $11.70M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 1.00M | — | $10.67M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Gotham Asset Management ✦ | 972.97K | — | $10.34M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 924.69K | — | $9.83M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Millennium Management ✦ | 751.20K | — | $7.99M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 378.62K | — | $4.02M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | GAMCO Investors ✦ | 326.13K | — | $3.47M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Fisher Asset Management ✦ | 215.61K | — | $2.29M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 176.07K | — | $1.87M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 176.07K | — | $1.87M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Two Sigma Investments ✦ | 162.80K | — | $1.73M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Capital World Investors ✦ | 110.68K | — | $1.18M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Wellington Management ✦ | 77.50K | — | $823,824 | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Wellington Management ✦ | 77.50K | — | $823,824 | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Wellington Management ✦ | 77.50K | — | $823,824 | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1,011 tenedores, 984.50M acciones, $12.02B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.